Graduate student Emma Casey of the Jin lab has been appointed to the Cellular and Molecular Biology (CMB) T32 Training Grant, a competitive program funded by the National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health (NIH).
Emma Casey, a second year PhD student in the Jin lab has been awarded a highly competitive NINDS Diversity Supplement to work on characterizing and assessing the impact of mitochondrial DNA variations in congenital hydrocephalus. Emma is the first trainee from the Department of Genetics to receive the significant 3-year NIH grant award totaling $225K. Congratulations!
Yung-Chun (David) Wang, PhD, an instructor in the Jin lab was recently awarded the Center of Regenerative Medicine’s hCTO microgrant. This microgrant will support his research into congenital hydrocephalus (CH), a developmental brain disorder characterized by abnormal cerebrospinal fluid accumulation.
Dr. Sheng Chih (Peter) Jin, has received a $3.2 million grant from the National Institutes of Health (NIH) to study the genetic and molecular underpinnings of congenital hydrocephalus.
Dr. Sheng Chih (Peter) Jin, Assistant Professor of Genetics, recently received his first R01 grant from the National Institute of Health (NIH), a milestone for his lab. In this article, Dr. Jin shares the story of his lab, research and what he enjoys most as a faculty member at WashU.
A new study led by WashU graduate student Shujuan Zhao, co-mentored by Dr. Sheng Chih (Peter) Jin, Assistant Professor of Genetics and Pediatrics, Washington University School of Medicine, and Dr. Kristopher T. Kahle, Director of Pediatric Neurosurgery, Massachusetts General Hospital, sheds light on new genetic mutations related to the disease and validations of the identified genes in mouse and zebrafish models. This collaborative work was recently published in Nature Communications.
Researchers at Washington University School of Medicine in St. Louis have received a five-year, $11.7 million grant to study human genes and nerve cells to better understand how cells transmit pain and to identify new ways to treat it.
Now, scientists have identified mutations in single genes that can be responsible for at least some cases of cerebral palsy, according to a new study led by researchers at Washington University School of Medicine in St. Louis, the University of Arizona College of Medicine in Phoenix, and Yale University.